Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Announces First Patient Enrolled in Confirmatory Clinical Trial of Aminolevulinic Acid Hydrochloride Powder for Oral Solution for Intraoperative Visualisation of Glioma
solution (the "Drug") for intraoperative visualisation of glioma (WHO grade III or IV) (the "Study") has recently been successfully enrolled in the Study.